PubRank

Eric Vivier

Author PubWeight™ 194.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Innate lymphoid cells--a proposal for uniform nomenclature. Nat Rev Immunol 2013 7.94
2 Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006 6.73
3 TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007 5.86
4 Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat Immunol 2008 4.78
5 The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013 4.60
6 Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol 2008 3.93
7 Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc Natl Acad Sci U S A 2007 3.60
8 Maturation of mouse NK cells is a 4-stage developmental program. Blood 2009 3.31
9 A novel dendritic cell subset involved in tumor immunosurveillance. Nat Med 2006 3.21
10 The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med 2009 3.17
11 Natural-killer cells and dendritic cells: "l'union fait la force". Blood 2005 3.10
12 Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. Nat Med 2011 3.03
13 CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med 2005 2.93
14 Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol 2002 2.87
15 Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med 2007 2.85
16 Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells. Blood 2009 2.75
17 The trafficking of natural killer cells. Immunol Rev 2007 2.62
18 Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci U S A 2005 2.55
19 NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J Immunol 2009 2.12
20 Germ-line and rearranged Tcrd transcription distinguish bona fide NK cells and NK-like gammadelta T cells. Eur J Immunol 2007 2.11
21 Cutting edge: Priming of NK cells by IL-18. J Immunol 2008 2.08
22 Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future. Immunol Rev 2008 2.05
23 Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc Natl Acad Sci U S A 2011 2.01
24 Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol 2007 2.00
25 Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses. Science 2012 1.98
26 Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses. J Immunol 2011 1.97
27 Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 2008 1.96
28 Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog 2007 1.93
29 Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt- lymphoid cells. EMBO J 2011 1.74
30 Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis. J Exp Med 2007 1.73
31 The speed of change: towards a discontinuity theory of immunity? Nat Rev Immunol 2013 1.72
32 Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood 2007 1.66
33 Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses. Curr Opin Immunol 2007 1.65
34 Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways. Blood 2008 1.56
35 Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies. Blood 2013 1.55
36 NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors. Nat Med 2012 1.52
37 The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells. J Immunol 2004 1.51
38 Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. Proc Natl Acad Sci U S A 2005 1.50
39 Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells. Blood 2005 1.50
40 Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors. Eur J Immunol 2004 1.48
41 Interferon-γ production by natural killer cells and cytomegalovirus in critically ill patients. Crit Care Med 2012 1.43
42 Multiplicity and plasticity of natural killer cell signaling pathways. Blood 2005 1.40
43 Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis. J Exp Med 2012 1.39
44 Membrane nanotubes facilitate long-distance interactions between natural killer cells and target cells. Proc Natl Acad Sci U S A 2010 1.38
45 Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. J Clin Invest 2012 1.35
46 Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J Exp Med 2002 1.33
47 Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance. Sci Signal 2011 1.30
48 Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat Immunol 2002 1.29
49 Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse. J Neurosci 2004 1.29
50 Syk regulation of phosphoinositide 3-kinase-dependent NK cell function. J Immunol 2002 1.28
51 Natural killer cells in human autoimmune diseases. Immunology 2010 1.27
52 DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections. J Immunol 2006 1.26
53 Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells. J Immunol 2004 1.26
54 Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression. Hepatology 2012 1.24
55 Interactions between human NK cells and macrophages in response to Salmonella infection. J Immunol 2009 1.23
56 Crystal structure of the human natural killer cell activating receptor KIR2DS2 (CD158j). J Exp Med 2003 1.22
57 Essential role of DAP12 signaling in macrophage programming into a fusion-competent state. Sci Signal 2008 1.22
58 Natural killer cell-dendritic cell crosstalk in the initiation of immune responses. Expert Opin Biol Ther 2005 1.22
59 KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions. Eur J Immunol 2005 1.21
60 Nfil3-independent lineage maintenance and antiviral response of natural killer cells. J Exp Med 2013 1.21
61 Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions. Blood 2013 1.19
62 NK cell MHC class I specific receptors (KIR): from biology to clinical intervention. Curr Opin Immunol 2012 1.18
63 Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells. J Exp Med 2003 1.18
64 Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo. Proc Natl Acad Sci U S A 2009 1.16
65 A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo. Blood 2008 1.16
66 Differential responses of immune cells to type I interferon contribute to host resistance to viral infection. Cell Host Microbe 2012 1.12
67 NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome. Sci Transl Med 2013 1.12
68 TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells. Nat Cell Biol 2013 1.12
69 DAP12 signaling regulates plasmacytoid dendritic cell homeostasis and down-modulates their function during viral infection. J Immunol 2006 1.11
70 B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors. Cell Mol Life Sci 2011 1.11
71 Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. Am J Pathol 2005 1.11
72 Mapping of NKp46(+) Cells in Healthy Human Lymphoid and Non-Lymphoid Tissues. Front Immunol 2012 1.10
73 Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study. PLoS One 2007 1.09
74 Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation. Eur J Immunol 2008 1.07
75 Coordination of activating and inhibitory signals in natural killer cells. Mol Immunol 2005 1.07
76 Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo - role of KARAP/DAP12-dependent and -independent pathways. Eur J Immunol 2004 1.06
77 Mouse CD146/MCAM is a marker of natural killer cell maturation. Eur J Immunol 2008 1.03
78 Massive inflammatory syndrome and lymphocytic immunodeficiency in KARAP/DAP12-transgenic mice. Eur J Immunol 2002 1.02
79 The role of natural killer cells in sepsis. J Biomed Biotechnol 2011 1.02
80 Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules. J Immunol 2004 1.02
81 G-protein-coupled receptors in control of natural killer cell migration. Trends Immunol 2011 1.01
82 IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules. J Immunol 2004 1.00
83 Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk. Eur Cytokine Netw 2002 0.99
84 Education of murine NK cells requires both cis and trans recognition of MHC class I molecules. J Immunol 2013 0.99
85 Natural killer cells and malaria. Immunol Rev 2006 0.98
86 Expression of the CD85j (leukocyte Ig-like receptor 1, Ig-like transcript 2) receptor for class I major histocompatibility complex molecules in idiopathic inflammatory myopathies. Arthritis Rheum 2008 0.96
87 Impact of β2 integrin deficiency on mouse natural killer cell development and function. Blood 2011 0.96
88 Tuning the threshold of natural killer cell responses. Curr Opin Immunol 2012 0.96
89 Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort. BMC Public Health 2012 0.96
90 Crosstalk between components of the innate immune system: promoting anti-microbial defenses and avoiding immunopathologies. Immunol Rev 2009 0.95
91 Features and distribution of CD8 T cells with human leukocyte antigen class I-specific receptor expression in chronic hepatitis C. Hepatology 2007 0.94
92 Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12. Eur J Immunol 2005 0.93
93 Natural killer cell-based therapies. F1000 Med Rep 2011 0.93
94 Dissection of the role of PfEMP1 and ICAM-1 in the sensing of Plasmodium-falciparum-infected erythrocytes by natural killer cells. PLoS One 2007 0.92
95 Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation. Mol Biol Cell 2003 0.92
96 Familial NK cell deficiency associated with impaired IL-2- and IL-15-dependent survival of lymphocytes. J Immunol 2006 0.91
97 Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest 2017 0.90
98 A nomenclature for signal regulatory protein family members. J Immunol 2005 0.90
99 Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population. PLoS One 2013 0.90
100 FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia. Eur J Immunol 2008 0.89
101 A novel developmental and immunodeficiency syndrome associated with intrauterine growth retardation and a lack of natural killer cells. Pediatrics 2004 0.89
102 T cell regulation of natural killer cells. J Exp Med 2013 0.87
103 Protection from inflammatory organ damage in a murine model of hemophagocytic lymphohistiocytosis using treatment with IL-18 binding protein. Front Immunol 2012 0.87
104 Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line. Eur J Immunol 2003 0.85
105 Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions. Eur J Immunol 2004 0.85
106 Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of gammadelta T cells. Eur J Immunol 2005 0.84
107 Phenotype and functions of natural killer cells in critically-ill septic patients. PLoS One 2012 0.84
108 Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells. Clin Immunol 2010 0.83
109 NK cell genesis: a trick of the trail. Immunity 2012 0.83
110 Immunology: Natural killer cells remember. Nature 2009 0.83
111 The 'T-cell-ness' of NK cells: unexpected similarities between NK cells and T cells. Int Immunol 2011 0.82
112 Natural killer cells are required for extramedullary hematopoiesis following murine cytomegalovirus infection. Cell Host Microbe 2013 0.82
113 [B7-H6 : a novel alert signal for NK cells]. Med Sci (Paris) 2010 0.80
114 Natural killer cell receptor signaling pathway. Sci STKE 2005 0.80
115 Natural killer cell tolerance: control by self or self-control? Cold Spring Harb Perspect Biol 2012 0.80
116 Evidence for early infection of nonneoplastic natural killer cells by Epstein-Barr virus. J Virol 2002 0.79
117 CD Antigens 2001. Mod Pathol 2002 0.79
118 When NK cells overcome their lack of education. J Clin Invest 2012 0.79
119 Increased diabetes development and decreased function of CD4+CD25+ Treg in the absence of a functional DAP12 adaptor protein. Eur J Immunol 2008 0.79
120 Reference: CD Antigens 2002. J Immunol 2002 0.79
121 Altered distribution and function of natural killer cells in murine and human Niemann-Pick disease type C1. Blood 2013 0.79
122 Inborn errors of the development of human natural killer cells. Curr Opin Allergy Clin Immunol 2013 0.79
123 [Natural killer cells: adaptation and memory in innate immunity]. Med Sci (Paris) 2013 0.78
124 CD antigens 2002. Blood 2002 0.78
125 NK cell development: gas matters. Nat Immunol 2006 0.77
126 Natural killer cell receptor signaling pathway in mammals. Sci STKE 2005 0.76
127 [NK cells and innate immunity to malaria]. Med Sci (Paris) 2006 0.76
128 A novel mucosal RORγtNKp46 cell subset is a source of interleukin-22. F1000 Biol Rep 2009 0.75
129 Lung natural killer cells play a major counter-regulatory role in pulmonary vascular hyperpermeability after myocardial infarction. Circ Res 2013 0.75
130 Since their identification 40 years ago, natural killer (NK) cells write a never-ending story. Introduction. Curr Top Microbiol Immunol 2016 0.75
131 Corrigendum: Evidence of innate lymphoid cell redundancy in humans. Nat Immunol 2016 0.75